In summary, the present data demonstrated that Rab32 in CD11c+ cells protects against the development of DSS‐induced colitis by preventing bacterial invasion and suggested that Rab32 might contribute to the pathogenesis of human IBD and IBD‐related colorectal carcinoma. Here, RAB32 is linked to inflammatory bowel disease.